[{"uuid": "a7ecb2a3-c9f4-4ebd-abb4-64ee7ff2240f", "publishTime": "2021-10-01T11:27:52.000Z", "title": "IsoPlexis sets IPO price range at $14 to $16 per share", "description": "Laboratory testing company IsoPlexis Corp. on Friday said it plans to sell 8.33 million shares at $14 to $16 a share in its upcoming initial public offering. The company plans to trade on the Nasdaq under the symbol ISO, with underwriters Morgan Stanley, Cowen, Evercore and SVB Leerink. At the midpoint of the range, IsoPlex's IPO will raise $125 million. IsoPlexis will have 40.1 million shares outstanding if underwriters exercise their share purchases, for a market capitalization of about $602 million. IsoPlexis reported a net loss of $36.1 million for the six months ended June 30 on revenue of $7.5 million, compared to a loss of $10.2 million and revenue of $3.7 million, in the year-ago period. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.", "assetTags": ["Svb Financial Group", "SIVB NASDAQ", "SIVB US"], "searchTags": ["SIVB"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/jgbhFlxaG2U/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 4, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/svb-financial-group-sivb"}, {"uuid": "cfe3b599-f5ac-48f5-a678-77466a12d69e", "publishTime": "2021-10-15T12:25:07.000Z", "title": "Minerva Surgical to offer 6.25 million shares in planned IPO, priced at $15 to $17 each", "description": "Minerva Surgical Inc. set terms for its initial public offering on Friday, with plans to offer 6.25 million shares, priced at $15 to $17 each. The company would raise $106.25 million at the top of that range, at a valuation of $486 million. The company has applied to list on Nasdaq, under the ticker 'UTRS.' JPMorgan, Piper Sandler, UBS and SVB Leerink are underwriting the deal. \"We are a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women,\" the company says in its IPO prospectus. The Renaissance IPO ETF has gained 3% in the year to date, while the S&P 500 has gained 18%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.", "assetTags": ["Svb Financial Group", "SIVB NASDAQ", "SIVB US"], "searchTags": ["SIVB"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/sMFBSorAEsk/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 4, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/svb-financial-group-sivb"}, {"uuid": "5caf5d99-9558-43d1-b6f1-cbf45218f8ba", "publishTime": "2021-10-08T10:22:36.000Z", "title": "IsoPlexis IPO priced in the middle of expected range, as the biotech raised $125 million", "description": "IsoPlexis Corp. is primed to go public Friday, after the Connecticut-based biotechnology company's initial public offering priced overnight at $15 a share, in the middle of the expected range of between $14 and $16 a share. The company sold 8.33 million shares in the IPO to raise $125.0 million. The IPO pricing valued the company at about $582.7 million. The stock is expected to begin trading on the Nasdaq some time after the open, under the ticker symbol \"ISO.\" Morgan Stanley, Cowen, Evercore ISI and SVB Leerink are the lead book-running managers. The company recorded a net loss of $42.7 million on revenue of $7.5 million for the six months ended June 30, after a loss of $13.2 million on revenue of $3.7 million in the same period a year earlier. The company is going public at a time when the Renaissance IPO ETF has gained 1.0% over the past three months while the S&P 500 has tacked on 1.8%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.", "assetTags": ["Svb Financial Group", "SIVB NASDAQ", "SIVB US"], "searchTags": ["SIVB"], "category": "major_publication", "url": "https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/CB7JsvJaE0E/story.aspx?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": null, "lang": "en", "cityfalconScore": 47, "additionalData": {}, "source": {"name": "marketwatch.com", "brandName": "MarketWatch", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/3682/large.png"}}, "duplicatesCount": 1, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/svb-financial-group-sivb"}, {"uuid": "3921a485-8600-45c8-962f-3e430e5106a0", "publishTime": "2021-09-23T00:00:00.000Z", "title": "Will SVB Financial Stock Continue Its Growth Trajectory?", "description": "SVB Financial Group\u00e2\u20ac\u2122s stock, increased by 7.7% in the last twenty-one trading days. In comparison, the broader S&P500 index fell by 2.2% over the same period. SVB Financial Group is a bank for start-ups and their investors, which offers commercial and private banking, asset management, private...", "assetTags": ["Svb Financial Group", "SIVB NASDAQ", "SIVB US"], "searchTags": ["SIVB"], "category": "major_publication", "url": "https://www.forbes.com/sites/greatspeculations/2021/09/23/will-svb-financial-stock-continue-its-growth-trajectory/?utm_campaign=cityfalcon&utm_medium=cityfalcon&utm_source=cityfalcon", "imageUrls": ["https://thumbor.forbes.com/thumbor/fit-in/1200x0/filters%3Aformat%28jpg%29/https%3A%2F%2Fspecials-images.forbesimg.com%2Fimageserve%2F614c043191f528ebeee03218%2F0x0.jpg"], "lang": "en", "cityfalconScore": 32, "additionalData": {}, "source": {"name": "forbes.com", "brandName": "Forbes", "imageUrl": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "imageUrls": {"thumb": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/thumb.png", "small": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/small.png", "medium": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/medium.png", "large": "https://cityfalconproduction.blob.core.windows.net/autotweetmedia/domains/logos/5846/large.png"}}, "duplicatesCount": 0, "paywall": false, "registrationRequired": false, "cityfalcon_permalink": "https://www.cityfalcon.com/news/directory/stocks/svb-financial-group-sivb"}]